Antipyretic therapy: Physiologic rationale, diagnostic implications, and clinical consequences

Archives of Internal Medicine

Volumn 160, Issue 4, 2000, Pages 449-456

  Plaisance, Karen I ^a   Mackowiak, Philip A ^b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPHENOL; ACETANILIDE; ACETYLSALICYLIC ACID; ALCOHOL; AMINOPHENAZONE; ANTIPYRETIC AGENT; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; DIPYRONE; ENDOTOXIN; IBUPROFEN; KETOPROFEN; KETOROLAC; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; PARACETAMOL; PHENACETIN; PHENOBARBITAL; PROSTAGLANDIN E2; PYRAZOLONE DERIVATIVE; SALICIN; SALICYLATE SODIUM; SALICYLIC ACID DERIVATIVE; WATER;

ANTIPYRETIC ACTIVITY; CLINICAL TRIAL; COOLING; FEBRILE CONVULSION; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; NONHUMAN; OXYGEN CONSUMPTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; REYE SYNDROME; RISK BENEFIT ANALYSIS; SHIVERING;

EID: 0034723766     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.4.449     Document Type: Review

References (103)

1. Vane JR, Botting RM. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med. 1998;104(suppl):2S-8S.
2. Jack DB. One hundred years of aspirin. Lancet. 1997;350:437-439.
3. Cooper KE. Fever and Antipyresis: The Role of the Nervous System. Cambridge, Mass: Cambridge University Press: 1995:100-105.
4. Piria R. Sur des nouveaux produits extraits de la salicin. C R Acad Sd Paris. 1838;6:620-624.
5. Gerland H. New formation of salicylic acid. J Chem Soc. 1852;5:133.
6. Kolbe H, Lautemann E. Über die Constitution und Basicität der Salicylsäure. Justus Liebigs Annals Chem. 1860;115:157-206.
7. von Gerhardt C. Untersuchungen über die wasserfreien organischen Sären. Justus Leibig Annals Chem. 1853;87:149-178.
8. Ipp M, Jaffe D. Physicians' attitudes toward the diagnosis and management of fever in children 3 months to 2 years of age. Clin Pediatr. 1993; 32:66-70.
9. Thomas V, Riegel B, Andrea J, Murray P, Gerhart A, Gocka I. National survey of pediatric fever management practices among emergency department nurses. J Emerg Nurs. 1994;20:505-510.
10. Eskerud JR, Andrew M, Stromnes B, Toverud EL. Pharmacy personnel and fever. Pharm World Sci. 1993;15:156-160.
11. Kramer MS, Niamark L, Leduc DG. Parental fever phobia and its correlates. Pediatrics. 1985; 75:1110-1113.
12. Kelly L, Morin K, Young D. Improving caretakers' knowledge of fever management in preschool children: is it possible? J Pediatr Health Care. 1996;10:167-173.
13. IUPS Thermal Commission. Glossary of Terms for Thermal Physiology. 2nded. Pflügers Arch. 1987;410:567-587.
14. Mackowiak PA, Bartlett JG, Borden EC, et al. Concepts of fever. Clin Infect Dis. 1997;25:119-138.
15. Kluger MJ, Kozak W, Conn CA, et al. The adaptive value of fever. In: Mackowiak PA, ed. Fever: Basic Mechanisms and Management. 2nd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1997:255-266.
16. Mackowiak PA. Fever: blessing or curse? a unifying hypothesis. Ann Intern Med. 1994;120: 1037-1040.
17. Mackowiak PA, Boulant JA. Fever's glass ceiling. Clin Infect Dis. 1996;22:525-536.
18. Hirtz DG. Generalized tonic clonic and febrile seizures. Pediatr Clin North Am. 1989;36:375-382.
19. Berg AT. Febrile seizures and epilepsy: the contributions of epidemiology. Pediatr Perinatal Epidemiol. 1992;6:145-152.
20. Lessell S, Torres JM, Kurland LT. Seizure disorders in a Guamanian village. Arch Neurol. 1962; 7:37-44.
21. Aicardi J. Febrile convulsions. In: Aicardi J, ed. Epilepsy in Children, 2nd ed. New York, NY: Raven Press; 1994:253-275.
22. Lennox-Buchthal MA. Febrile Convulsions: A Reappraisal. Amsterdam, the Netherlands: Elsevier Science Inc; 1973:1-138.
23. Rosman NP. Febrile convulsions. In: Mackowiak PA, ed. Fever: Basic Mechanisms and Management. 2nd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1997:267-277.
24. Styrt B, Sugarman B. Antipyresis and fever. Arch Intern Med. 1990;150:1589-1597.
25. Greisman SE. Cardiovascular alterations during fever. In: Mackowiak PA, ed. Fever: Basic Mechanisms and Management. 2nd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1997:143-165.
26. Horwath SM, Spurr GB, Hurt BK, Hamilton LH. Metabolic cost of shivering. J Appl Physiol. 1956; 8:595-602.
27. Mackowiak PA, Plaisance KI. The benefits and risks of antipyretic therapy. Ann N Y Acad Sci. 1998;856:214-223.
28. Mackowiak PA. Concepts of fever. Arch Intern Med. 1998;158:1870-1881.
29. Grundmann MJ. Studies on the Action of Antipyretic Substances [doctor of philosophy thesis]. Oxford, England: University of Oxford; 1969.
30. Milton AS, Wendlandt S. Effects on body temperature of prostaglandins of the A, E and F series on injection into the third ventricle of unanaesthetized cats and rabbits. J Physiol (Lond). 1971;218:325-336.
31. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol. 1971;231:232-235.
32. Mitchell D, Laburn H, Cooper KE, Hellon RF, Cranston WI, Townsend Y. Is prostaglandin E the neural mediator of the febrile response? The case against a proven obligatory role. Yale J Biol Med. 1986;59:159-168.
33. Alexander SJ, Cooper KE, Veale WL. Sodium salicylate: alternate mechanism of central antipyretic action in the rat. Pflügers Arch. 1989;413: 451-455.
34. Blatteis CM, Sehic E. Proslaglandin E2: a putative fever mediator. In: Mackowiak PA, ed. Fever: Basic Mechanisms and Management. 2nd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1997:117-145.
35. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998; 38:97-120.
36. Vane JR, Botting RM. New insights into the mode of action of anti-inflammatory drugs. Inflamm Res. 1995;44:1-10.
37. Flower RJ, Vane JR. Inhibition of prostaglandin synthetase in brain explains the antipyretic activity of paracetamol (4-acetamidophenol). Nature. 1972;240:410-411.
38. Insel PA. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill Co; 1996:617-657.
39. Carabaza A, Cabre F, Rotllan E, et al. Stereos-elective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugs. J Clin Pharmacol. 1996;36:505-512.
40. Evans AM. Pharmacodynamics and pharmacokinetics of the profens: enantioselectivity, clinical implications, and special reference to S(+)-ibuprofen. J Clin Pharmacol. 1996;36(suppl):7s-15s.
41. Kelley MT, Walson PD, Edge JH, Cox S, Mortensen ME. Pharmacokinetics and pharmacodynamics of ibuprofen isomers and acetaminophen in febrile children. Clin Pharmacol Ther. 1992;52:181-189.
42. Spinos GA, Bloesch D, Keller U, Zimmerli W, Cammisuli S. Pretreatment with ibuprofen augments circulating tumor necrosis factor-α, interleukin-6 and elastase during acute endotoxinemia. J Infect Dis. 1991;163:89-95.
43. Nahata MC, Powell DA, Durrell DE, Miller MA, Gupta N. Efficacy of ibuprofen in pediatric patients with fever. Int J Clin Pharmacol Ther Toxicol. 1992;30:94-96.
44. Autret E, Breart G, Jonville AP, Courcier S, Lassale C, Goehrs JM. Comparative efficacy and tolerance of ibuprofen syrup in children with pyrexia associated with infectious diseases and treated with antibiotics. Eur J Clin Pharamcol. 1994;46:197-201.
45. Walson PD, Galletta G, Braden NJ, Alexander L. Ibuprofen, acetaminophen, and placebo treatment of febrile children. Clin Pharmacol Ther. 1989;46:9-17.
46. Wilson JT, Brown RD, Kearns GL, et al. Single-dose, placebo-controlled comparative study of ibuprofen and acetaminophen antipyresis in children. J Pediatr. 1991;119:803-811.
47. McIntyre J, Hull D. Comparing efficacy and folerability of ibuprofen and paracetamol in fever. Arch Dis Child. 1996;74:164-167.
48. Kauffman RE, Sawyer LA, Scheinbaum ML. Antipyretic efficacy of ibuprofen vs acetaminophen. AJDC. 1992;146:622-625.
49. Walson PD, Galletta G, Chomilo F, Braden MJ, Sawyer LA, Scheinbaum ML. Comparison of multidose ibuprofen and acetaminophen therapy in febrile children. AJDC. 1992;146:626-632.
50. Marriott SC, Stepnenson TJ, Hull D, Pownall R, Smith CM, Butler A. A dose ranging study of ibuprofen susupension as an antipyretic. Arch Dis Child. 1991;66:1037-1041.
51. Van Esch A, Van Stennsel-Moll HA, Steyerberg EW, Offringa M, Habbema JDF, Derksen-Lubsen G. Antipretic efficacy of ibuprofen and acetaminophen in children with febrile seizures. Arch Pediatr Adolesc Med. 1995;149:632-637.
52. Lecomte J, Monti T, Pochobradsky MG. Antipyretic effects of nimesulide in paediatric practice: a double-blind study. Curr Med Res Opin. 1991;12:296-303.
53. D'Apuzzo V, Monti T. Pilot study of the antipyretic and analgesic activity of nimesulide paediatric suppositories. Drugs Exp Clin Res. 1992;18:63-68.
54. Michie HR, Manouge KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988; 318:1481-1486.
55. Bernard GR, Wheller AP, Russell JA, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med. 1997; 336:912-918.
56. Vargas R, Maneatis T, Bynum L, Peterson C, McMahon FG. Evaluation of the antipyretic effect of ketorolac, acetaminophen, and placebo in endotoxin-induced fever. J Clin Pharmacol. 1994; 34:848-853.
57. Reiner M, Massera E, Magni E. Nimesulide in the treatment of fever: a double-blind, crossover clinical trial. J Int Med Res. 1984;12:102-107.
58. Cunietti E, Monti M, Vigano A, et al. Nimesulide in the treatment of hyperpyrexia in the aged: double-blind comparison with paracetamol. Arzneim-Forsch Drug Res. 1993;43:160-162.
59. Reiner M, Cereghetti S, Haeusermann M, Monti T. Antipyretic activity of nimesulide suppositories: double blind versus diclofenac and placebo. Int J Clin Pharmacol Ther Toxicol. 1985; 23:673-677.
60. Hurwitz ES, Barrett MJ, Bregman D, et al. Public health service study on Reye's syndrome and medications: report of the pilot phase. N Engl J Med. 1985;313:849-857.
61. Hurwitz ES, Marret MJ, Bregman D, et al. Public health service study of Reye's syndrome and medications: report of the main study. JAMA. 1987;257:1905-1911.
62. Rahwan GL, Rahwan RG. Aspirin and Reye's syndrome: the change in prescribing habits of health professionals. Drug Intell Clin Pharm. 1986;20: 143-145.
63. Brooks P. Use and benefits of nonsteroidal anti-inflammatory drugs. Am J Med. 1998;104 (suppl 3A):9S-13S.
64. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis. Ann Intern Med. 1991; 115:787-796.
65. Graham DY, Smith JL. Aspirin and the stomach. Ann Intern Med. 1986;104:390-398.
66. Graham DY, Smith JL, Spjut HJ, Torres E. Gastric adaptation: studies in humans during continuous aspirin administration. Gastroenterology. 1988;95:327-333.
67. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen: a practitioner-based randomized clinical trial. JAMA. 1995;273:929-933.
68. Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med. 1997;337:1112-1117.
69. Whitcomb DC, Block GD. Association of acetaminophen hepatotoxiicty with lasting and alcohol use. JAMA. 1994;272:1845-1850.
70. Oldach DW, Richard R, Borza EN, Benitez RM. "Amysterious death." N Engl J Med. 1998;338: 1764-1769.
71. O'Donnell J, Axelrod P, Fisher C, Lorber B. Use and effectiveness of hypothermia blankets for febrile patients in the intensive care unit. Clin Infect Dis. 1997;24:1208-1213.
72. Wenzel C, Werner J. Physical versus pharmacological counter-measures. Eur J Appl Physiol. 1988;57:81-88.
73. Steele RW, Tanaka PT, Lara RP, Bass JW. Evaluation of sponging and of oral antipyretic therapy to reduce fever. J Pediatr. 1970;77:824-829.
74. Newman J. Evaluation of sponging to reduce body temperature in febrile children. CMAJ. 1985; 132:641-642.
75. McCarthy PL, Grundy GW, Spiesel SZ, Dolan TF. Bacteremia in children: an outpatient clinical review. Pediatrics. 1976;57:861-868.
76. McGowan JE, Bratton L, Klein JO, Finland M. Bacteremia in febrile children seen in a "walk-in" pediatric clinic. N Engl J Med. 1973;288:1309-1312.
77. Teele DW, Pelton SI, Grant MJ, et al. Bacteremia in febrile children under 2 years of age: results of cultures of blood of 600 consecutive febrile children seen in a "walk-in" clinic. J Pediatr. 1975;87:227-230.
78. Bonadio WA, Romine K, Gyuro J. Relationship of fever magnitude to rate of serious bacterial infections in neonates. J Pediatr. 1990;116:733-735.
79. McCarthy PL. Fever in infants and children. In: Mackowiak PA, ed. Fever: Basic Mechanisms and Management. 2nd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1997:351-362.
80. Toney SB, Henretig F, Fleisher G, et al. Temperature response to antipyretic therapy in children: relationship to occult bacteremia. Am J Emerg Med. 1985;3:190-192.
81. Baker MD, Fosarelli PD, Carpenter RO. Childhood fever: correlation of diagnosis with temperature response to acetaminophen. Pediatrics. 1987;80:315-318.
82. Yamamoto LT, Wigder HN, Fligner DJ, et al. Relationship of bacteremia to antipyretic therapy in febrile children. Pediatr Emerg Care. 1987;3: 223-227.
83. Weisse ME, Miller G, Brien JH. Fever response to acetaminophen in viral vs. bacterial infections. Pediatr Infect Dis J. 1987;6:1091-1094.
84. Baker RC, Tiller T, Bausher JC, et al. Severity of disease correlated with fever reduction in febrile infants. Pediatrics. 1989;83:1016-1019.
85. Mazur LJ, Jones TM, Kozinetz CA. Temperature response to acetaminophen and risk of occult bacteremia: a case-control study. J Pediatr. 1989; 115:888-891.
86. Chang JC, Gross HM. Utility of naproxen in the differential diagnosis of fever of undetermined origin in patients with cancer. Am J Med. 1984; 76:597-603.
87. Chang JC. NSAID test to distinguish between infectious and neoplastic fever in cancer patients. Postgrad Med. 1988;84:71-72.
88. Tsavaris N, Zinelis A, Karabelis A, et al. A randomized trial of the effect of three non-steroidal anti-inflammatory agents in ameliorating cancer-induced fever. J Intern Med. 1990;228:451-455.
89. Manthores CA, Hall JB, Olson D, et al. Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Respir Crit Care Med. 1995; 151:10-14.
90. Raizner AE, Chahine RA, Ishimori T, et al. Provocation of coronary artery spasm by the cold pressor test: hemodynamic, arteriographic and quantitative arteriographic observations. Circulation. 1980;62:925-932.
91. Nobel EG, Gang P, Gordon JB, et al. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation. 1987;77:43-52.
92. Lenhardt R, Kurz A, Sessler DI. Thermoregulation and hyperthermia. Acta Anaesthesiol Scand Suppl. 1996;109:34-38.
93. Friedman PL, Brown EJ Jr, Gunther S, et al. Coronary vasoconstrictor effect of indomethacin in patients with coronary artery disease. N Engl J Med. 1981;305:1171-1175.
94. Isaacs SN, Axelrod PI, Lorber B. Antipyretic orders in a university hospital. Am J Med. 1990;88: 31-35.
95. Dorna TF, DeAngelis C, Baumgardner RA, et al. Acetaminophen: more harm than good for chicken pox? J Pediatr. 1989;114:1045-1048.
96. Stanley ED, Jackson GG, Panusarn C, et al. Increased viral shedding with aspirin treatment of rhinovirus infection. JAMA. 1975;231:1248-1251.
97. Graham MH, Burrell CJ, Douglas RM, et al. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis. 1990;162:1277-1282.
98. Brandts CH, Ndjavé M, Graninger W, Kremsner PG. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet. 1997;350:704-709.
99. Beisel WR, Morgan BB Jr, Bartelloni PJ, et al. Symptomatic therapy in viral illness. A controlled study of effects on work performance. JAMA. 1974;228:581-584.
100. Camfield PR, Camfield CS, Shapiro SH, et al. The first febrile seizure: antipyretic instruction plus either phenobarbital or placebo to prevent recurrence. J Pediatr. 1980;5:719-737.
101. Uhari M, Rantala H, Vainionpää L, et al. Effect of acetaminophen and of low intermittent doses of diazepam on prevention of recurrences of febrile seizures. J Pediatr. 1995;126:991-995.
102. Schnaiderman D, Lahat E, Sheefer T, et al. Antipyretic effectiveness of acetaminophen in febrile seizures: ongoing prophylaxis versus sporadic usage. Eur J Pediatr. 1993;152:747-749.
103. Warren HS. Strategies for the treatment of sepsis. N Engl J Med. 1997;336:952-953.